Answers are grounded in this paper and cite their sources.
Virtual trial evaluates Bayesian dosing of vancomycin in neonates, indicating improved drug exposure for better care.
BACKGROUND AND OBJECTIVES: ) is often used as a surrogate. This virtual TDM study aimed to evaluate the performance of Bayesian model-informed precision dosing (MIPD) for vancomycin in neonates. METHODS: with the reference value. RESULTS: prediction. CONCLUSION: This virtual TDM study indicates that Bayesian MIPD optimizes vancomycin exposure in neonates, while simplifying the sampling strategy. This approach deserves to be integrated and validated in routine neonatal care.
No takes yet. Share an insight, caveat, or question.
Ravix et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: